Earnings Scheduled For May 4, 2022
Companies Reporting Before The Bell
• Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.
Stocks That Hit 52-Week Lows On Friday
During Friday's morning session, 234 stocks hit new 52-week lows.
Earnings Scheduled For March 3, 2022
Companies Reporting Before The Bell
• Travelzoo (NASDAQ:TZOO) is expected to report quarterly earnings at $0.13 per share on revenue of $18.23 million.
Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 109 companies set new 52-week lows.
Rain Therapeutics And Roche To Collaborate On Clinical Trial Of Milademetan Combination With Anti-PD-L1 Immunotherapy For Various Solid Tumor Indications
Rain Therapeutics Inc. (NASDAQ:RAIN), ("Rain"), a late-stage company developing precision oncology therapeutics, today announced a clinical supply agreement with Roche ((SIX: RO, ROG, OTCQX:RHHBY) for the
Rain Therapeutics Q3 EPS $(0.70) Up From $(3.05) YoY
Rain Therapeutics (NASDAQ:RAIN) reported quarterly losses of $(0.70) per share. This is a 77.05 percent increase over losses of $(3.05) per share from the same period last year.